1 / 21

Department of ART for Infertility Treatmet

Department of ART for Infertility Treatmet Research Centre of Ob/ Gyn & Perinatology Named After V.I. Kulakov Ministry of Health And Social Development of Russian Federation. Zhanna Glinkina.

demetria-vance
Download Presentation

Department of ART for Infertility Treatmet

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Department of ART for Infertility Treatmet Research Centre of Ob/Gyn &Perinatology Named After V.I. Kulakov Ministry of Health And Social Development of Russian Federation ZhannaGlinkina Assistive Reproductive Technologies (ART) Outcomes Optimization Thought PGD: Role of Medico-genetic Factors

  2. More than 30 years of IVF in the world!

  3. Developed and applied new drugs for ART programs; 2. developed new protocols ART; 3. introduced new technologies (ICSI, PGD, TESA,        cryopreservation of embryos, etc.)   ART program provided an opportunity to have children to couples with previously untreatable forms of infertility

  4. 1. Reproductive behavior changed man;2. changed the patients included in the program ART (patients with cancer history, patients with genetic disorders, etc.)

  5. Must exercise great caution when conducting genetic program of ART in this group of patients

  6. Scientific - practical activities of VRT offices in different countries has shown that changes in genotype among patients with impaired reproductive function occur much more frequently than in the population. Reproductive disorders are usually caused by chromosomal and gene mutations, the presence of a hereditary predisposition to the disease. Mutations in the parents, leading to disruption of reproduction and the impossibility of conceiving a child naturally, the application program VRT can be transmitted through the gametes of the future offspring.

  7. Patients IVF in 29 couples out of 391 (7.4%), one of the spouses had changes in the karyotype (24 women, 5 men, 3.7%)   In the group of patients ICSI program In 37 couples out of 558 (6.6%), one of the spouses had changes in the karyotype (7 women, 30 men, 3.3%) The level of chromosomal aberrations in the population - 0.5%

  8. Heterozygous carriers of mutations CYP21V different methods were found in 37.1% of cases Of all the identified mutations in men and women in both groups, deletions of CYP21B gene was 70.7%; duplication - 24.4%.

  9. Mutations in the CFTR gene were detected in 14.8% of patients

  10. AZF microdeletions of the Y chromosome loci were detected in 15.1% of patients ICSI program

  11. conclusion:The high frequency of chromosomal and genetic changes in the genotype of patients ART program determines the need for medical genetic counseling and cytogenetic survey of both spouses and on the testimony of the molecular - genetic survey to include them in IVF / ICSI.

  12. Results of the study of chorion

  13. What does the PGD? • 2) reducing the frequency of spontaneous abortions;3) reduction in the incidence of multiple of pregnancies. 1) The birth of healthy offspring;

  14. ART in couples where the husband has patozoospermiya

  15. After biopsy blastomeres, further development of embryos is observed in 90-95% of cases

  16. Analysis of the results of PGD Patients with genetic mutations showed that 23% of the patients in this group of patients on genetic criteria are no embryos suitable for transfer

  17. 10th International Congress on Preimplantation Genetic Diagnosis 5-8 May 2010, Montpellier, France

  18. Prospects of development of PGD 1) Identification of mutations in the embryo of fertile couples, but with a high risk of birth of offspring with genetic disorders;2) identification of HLA antigens embryosselection of donor leukocyte antigen identical toa sick child - brother / sister;3) identification of a genetic predisposition tosevere diseases (oncology, Alzheimer's disease andetc.);4) The selection of embryos with specific phenotypictraits - eye color, hair, married couples, benefited from donor cells in the IVF

  19. Thank you for your attention Zh. Glinkina.

More Related